Factor XI as a target for antithrombotic therapy

Drug Discovery Today

Volumn 19, Issue 9, 2014, Pages 1454-1458

  Bane, Charles E ^a   Gailani, David ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTISENSE OLIGONUCLEOTIDE; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 11A; MONOCLONAL ANTIBODY; THROMBIN; FIBRINOLYTIC AGENT;

ANTICOAGULANT THERAPY; BLEEDING; BLOOD CLOTTING FACTOR 11 DEFICIENCY; CLINICAL PRACTICE; DISEASE SEVERITY; DRUG BINDING; DRUG BINDING SITE; DRUG EFFICACY; DRUG SAFETY; DRUG TARGETING; HEMOSTASIS; HUMAN; NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); PROTEIN TARGETING; REVIEW; THROMBOEMBOLISM; THROMBOSIS; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD CLOTTING; CHEMICALLY INDUCED; DRUG DESIGN; DRUG EFFECTS; HEMORRHAGE; PHYSIOLOGY;

ANIMALS; ANTICOAGULANTS; BLOOD COAGULATION; DRUG DESIGN; FACTOR XI; FACTOR XIA; FIBRINOLYTIC AGENTS; HEMORRHAGE; HUMANS; THROMBOEMBOLISM;

EID: 84907809913     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2014.05.018     Document Type: Review

References (41)

1. J. Emsley Structure and function of factor XI Blood 115 2010 2569 2577
2. D. Gailani Factor XI and the contact system B.A. Valle, The Online Metabolic and Molecular Basis of Inherited Disease 2010 Lippincott, Williams and Wilkins
3. R. He Factor XI: hemostasis, thrombosis and antithrombosis Thromb. Res. 129 2012 541 550
4. E.C. Löwenberg Coagulation factor XI as a novel target for antithrombotic treatment J. Thromb. Haemost. 8 2010 2349 2357
5. th edn 2013 Saunders-Elsevier 1174 1783
6. N. Mackman Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis Arterioscler. Thromb. Vasc. Biol. 27 2007 1687 1693
7. th edn 2013 Saunders-Elsevier 1939 1952
8. th edn 2013 Saunders-Elsevier 2067 2082
9. M.A. Wanat Novel oral anticoagulants: a review of new agents Postgrad. Med. 125 2013 103 114
10. Y. Geng A sequential mechanism for exosite-mediated factor IX activation by factor XIa J. Biol. Chem. 287 2012 38200 38209
11. A. Matafonov Activation of factor XI by products of prothrombin activation Blood 118 2011 437 445
12. S. Duga, and O. Salomon Congenital factor XI deficiency: an update Semin. Thromb. Hemost. 39 2013 621 631
13. O. Salomon Variable bleeding manifestations characterize different types of surgery in patients with severe factor XI deficiency enabling parsimonious use of replacement therapy Haemophilia 12 2006 490 493
14. J.C. Meijers High levels of coagulation factor XI as a risk factor for venous thrombosis N. Engl. J. Med. 342 2000 696 701
15. A. van Hylckama Vlieg High levels of factor IX increase the risk of venous thrombosis Blood 95 2000 3678 3682
16. C.J. Doggen Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: opposite and synergistic effects of factors XI and XII Blood 108 2006 4045 4051
17. D.T. Yang Elevated factor XI activity levels are associated with an increased odds ratio for cerebrovascular events Am. J. Clin. Pathol. 126 2006 411 415
18. O. Salomon Patients with severe factor XI deficiency have a reduced incidence of deep-vein thrombosis Thromb. Haemost. 105 2011 269 273
19. O. Salomon Reduced incidence of ischemic stroke in patients with severe factor XI deficiency Blood 111 2008 4113 4117
20. Q. Cheng A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo Blood 116 2010 3981 3989
21. X. Wang Effects of factor IX or factor XI deficiency on ferric chloride-induced carotid artery occlusion in mice J. Thromb. Haemost. 3 2005 695 702
22. E.I. Tucker Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI Blood 113 2009 936 944
23. T. Renné Defective thrombus formation in mice lacking coagulation factor XII J. Exp. Med. 202 2005 271 281
24. Y. Geng Analysis of the factor XI variant Arg184Gly suggests a structural basis for factor IX binding to factor XIa J. Thromb. Haemost. 11 2013 1374 1384
25. A. Matafonov Evidence for factor IX-independent roles for factor XIa in blood coagulation J. Thromb. Haemost. 11 2013 2118 2127
26. A. Matafonov Factor XII inhibition reduces thrombus formation in a primate thrombosis model Blood 123 2014 1739 1746
27. H. Zhang Inhibition of the intrinsic coagulation pathway factor XI by antisense oligonucleotides: a novel antithrombotic strategy with lowered bleeding risk Blood 116 2010 4684 4692
28. J.R. Crosby Antithrombotic effect of antisense factor XI oligonucleotide treatment in primates Arterioscler. Thromb. Vasc. Biol. 33 2013 1670 1678
29. J.W. Yau Selective depletion of factor XI or factor XII with antisense oligonucleotides attenuates catheter thrombosis in rabbits Blood 123 2014 2102 2107
30. Rx, a novel and specific antisense inhibitor of factor XI, caused significant reduction in FXI antigen and activity and increased aPTT without causing bleeding in healthy volunteers Blood 118 2011 Abstract 209
31. T.I. Lazarova Synthesis and in vitro biological evaluation of aryl boronic acids as potential inhibitors of factor XIa Bioorg. Med. Chem. Lett. 16 2006 5022 5027
32. H. Deng Synthesis, SAR exploration, and X-ray crystal structures of factor XIa inhibitors containing an alpha-ketothiazole arginine Bioorg. Med. Chem. Lett. 16 2006 3049 3054
33. P.C. Wong A small-molecule factor XIa inhibitor produces antithrombotic efficacy with minimal bleeding time prolongation in rabbits J. Thromb. Thrombolysis 32 2011 129 137
34. M.L. Quan Tetrahydroquinoline derivatives as potent and selective factor XIa inhibitors J. Med. Chem. 57 2014 955 969
35. R. Karuturi Discovery of allosteric modulators of factor XIa by targeting hydrophobic domains adjacent to its heparin-binding site J. Med. Chem. 56 2013 2415 2428
36. Y. Geng Factor XI anion-binding sites are required for productive interactions with polyphosphate J. Thromb. Haemost. 11 2013 2020 2028
37. R.A. Al-Horani Sulfated pentagalloylglucoside is a potent, allosteric, and selective inhibitor of factor XIa J. Med. Chem. 56 2013 867 878
38. M.S. Buchanan Clavatadine A, a natural product with selective recognition and irreversible inhibition of factor XIa J. Med. Chem. 51 2008 3583 3587
39. D. Ma Desmolaris, a novel factor XIa anticoagulant from the salivary gland of the vampire bat (Desmodus rotundus) inhibits inflammation and thrombosis in vivo Blood 122 2013 4094 4106
40. G.J. Broze, and T.J. Girard Tissue factor pathway inhibitor: structure-function Front. Biosci. 17 2012 262 280
41. B.A. McMullen Location of the disulfide bonds in human coagulation factor XI: the presence of tandem apple domains Biochemistry 30 1991 2056 2060